Study on Ketamine's Impact on Anaesthesia Depth Consistency in Laparoscopic Surgery
This study could significantly influence anaesthesia practices by validating ketamine's role as an adjunct therapy, potentially altering the competitive landscape for anaesthetic agents. A successful outcome may lead to revised clinical guidelines and increased adoption of ketamine in anaesthesia protocols.
Phase III
Anesthesia / Ketamine
Status
Active
Signal Score
8.2
Signal assessment
Signal strength
high
Confidence level
moderate
Strategic implication
This study could significantly influence anaesthesia practices by validating ketamine's role as an adjunct therapy, potentially altering the competitive landscape for anaesthetic agents. A successful outcome may lead to revised clinical guidelines and increased adoption of ketamine in anaesthesia protocols.
Why it matters
This study could significantly influence anaesthesia practices by validating ketamine's role as an adjunct therapy, potentially altering the competitive landscape for anaesthetic agents. A successful outcome may lead to revised clinical guidelines and increased adoption of ketamine in anaesthesia protocols.
What changed
Trial Update
Analysis
A randomized controlled study is set to evaluate the effect of subanaesthetic ketamine on anaesthesia depth consistency during laparoscopic surgery using automated propofol TIVA.
This study could significantly influence anaesthesia practices by validating ketamine's role as an adjunct therapy, potentially altering the competitive landscape for anaesthetic agents. A successful outcome may lead to revised clinical guidelines and increased adoption of ketamine in anaesthesia protocols.
Monitor results from the trial for efficacy outcomes and any changes in clinical practice guidelines regarding anaesthesia management.
Related companies & assets
Assets
Sources & Humanexa intelligence
Related signals
Newsletter
Get signals before the market moves
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.